ASPIC

envie a um amigo share this

A hipermetilação do miR-130b-301b afeta a senescência no cancro próstatico

O grupo de Epigenética & Biologia do Cancro do Centro de Investigação do IPO do Porto em colaboração com colegas do grupo de Epigenética e Biologia do Cancro do Instituto de Investigação Biomédica de Bellvitge, em Barcelona, Espanha, demonstraram recentemente na revista Journal of Hematology & Oncology, que a hipermetilação do promotor do cluster miR-130b-301b causa desregulação da senescência em cancro da Próstata (CaP). O CaP é uma doença heterogénea, sendo, actualmente, a neoplasia maligna não-cutânea mais comum em homens nos países desenvolvidos.

Genes and Cancer – 32nd Annual meeting

Robinson College at the University of Cambridge, Cambridge, United Kingdom

 

10 - 12 April, 2017

 

See more informations here: http://www.genesandcancer.org.uk/

Genes and Cancer – 32nd Annual meeting

Robinson College at the University of Cambridge, Cambridge, United Kingdom

 

10 - 12 April, 2017

 

See more informations here: http://www.genesandcancer.org.uk/

HDIR Symposium: New Advances in Radio and Immuno Therapy of Cancer

Zagreb, Croatia

 

30 March, 2017

 

See more informations here: http://www.hdir.hr/

HDIR Symposium: New Advances in Radio and Immuno Therapy of Cancer

Zagreb, Croatia

 

30 March, 2017

 

See more informations here: http://www.hdir.hr/

3rd EACR Conference on Cancer Genomics

Churchill College, Cambridge, United Kingdom

 

25 - 28 June, 2017

 

See more informations here: https://www.eacr.org/conference/cancergenomics2017

3rd EACR Conference on Cancer Genomics

Churchill College, Cambridge, United Kingdom

 

25 - 28 June, 2017

 

See more informations here: https://www.eacr.org/conference/cancergenomics2017

7th EACR-OECI Joint Training Course: Molecular Pathology Approach to Cancer

De Rode Hoed, Amsterdam, Netherlands

 

8 - 10 May 2017

 

See more informations here: http://www.eacr.org/conference/molecularpathology2017

 

7th EACR-OECI Joint Training Course: Molecular Pathology Approach to Cancer

De Rode Hoed, Amsterdam, Netherlands

 

8 - 10 May 2017

 

See more informations here: http://www.eacr.org/conference/molecularpathology2017

 

New copper(I) and copper(I)-ruthenium(II) complexes promising for cancer therapy

Authors and Affiliations:

João Lopesa,c, David Alvesa,c, Tânia S. Moraisa,b,c, Paulo J. Costac,d, M. Fátima M. Piedadec,e, Fernanda Marquesf, Maria J. Villa de Britoa,c, M. Helena Garciaa,c

a Centro de Química Estrutural, Faculdade de Ciências, Universidade de Lisboa, Portugal

b Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Portugal